These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10600691)

  • 21. Using the genome to understand pathogenicity.
    Field D; Hughes J; Moxon ER
    Methods Mol Biol; 2004; 266():261-87. PubMed ID: 15148423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using genomics to develop novel antibacterial therapeutics.
    Nagaraj NS; Singh OV
    Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targets and assays for discovering novel antibacterial agents.
    Donadio S; Carrano L; Brandi L; Serina S; Soffientini A; Raimondi E; Montanini N; Sosio M; Gualerzi CO
    J Biotechnol; 2002 Nov; 99(3):175-85. PubMed ID: 12385707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence as a target for antimicrobial chemotherapy.
    Alksne LE
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1149-59. PubMed ID: 12150708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling novel broad-spectrum antibacterial targets in food and waterborne pathogens using comparative genomics and protein interaction network analysis.
    Jadhav A; Shanmugham B; Rajendiran A; Pan A
    Infect Genet Evol; 2014 Oct; 27():300-8. PubMed ID: 25128740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivering novel targets and antibiotics from genomics.
    Payne DJ; Holmes DJ; Rosenberg M
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel virulence-associated genes via genome analysis of hypothetical genes.
    Garbom S; Forsberg A; Wolf-Watz H; Kihlberg BM
    Infect Immun; 2004 Mar; 72(3):1333-40. PubMed ID: 14977936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated pathway-genome databases and their role in drug discovery.
    Karp PD; Krummenacker M; Paley S; Wagg J
    Trends Biotechnol; 1999 Jul; 17(7):275-81. PubMed ID: 10370234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolutionary rate of antibacterial drug targets.
    Gladki A; Kaczanowski S; Szczesny P; Zielenkiewicz P
    BMC Bioinformatics; 2013 Feb; 14():36. PubMed ID: 23374913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequencing microbial genomes--what will it do for microbiology?
    Jenks PJ
    J Med Microbiol; 1998 May; 47(5):375-82. PubMed ID: 9879937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional genomics of bacterial pathogens: from post-genomics to therapeutic targets.
    Polissi A; Soria MR
    Mol Microbiol; 2005 Jul; 57(2):307-12. PubMed ID: 15978065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens.
    Barh D; Jain N; Tiwari S; Parida BP; D'Afonseca V; Li L; Ali A; Santos AR; Guimarães LC; de Castro Soares S; Miyoshi A; Bhattacharjee A; Misra AN; Silva A; Kumar A; Azevedo V
    Chem Biol Drug Des; 2011 Jul; 78(1):73-84. PubMed ID: 21443692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative phylogenomics of pathogenic bacteria by microarray analysis.
    Dorrell N; Hinchliffe SJ; Wren BW
    Curr Opin Microbiol; 2005 Oct; 8(5):620-6. PubMed ID: 16125441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encyclopedia of bacterial gene circuits whose presence or absence correlate with pathogenicity--a large-scale system analysis of decoded bacterial genomes.
    Shestov M; Ontañón S; Tozeren A
    BMC Genomics; 2015 Oct; 16():773. PubMed ID: 26459834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents.
    Pucci MJ
    Drugs R D; 2007; 8(4):201-12. PubMed ID: 17596107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The targets of currently used antibacterial agents: lessons for drug discovery.
    Lange RP; Locher HH; Wyss PC; Then RL
    Curr Pharm Des; 2007; 13(30):3140-54. PubMed ID: 17979755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobials: targeting virulence genes necessary for intracellular multiplication.
    Liautard JP; Jubier-Maurin V; Boigegrain RA; Köhler S
    Trends Microbiol; 2006 Mar; 14(3):109-13. PubMed ID: 16469497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.